Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia
Background This study investigated the cost-effectiveness of using fenofibrate to treat type 2 diabetes in Australia. The financial burden of type 2 diabetes mellitus is estimated to surpass AUD10 billion, mainly due to the cost of diabetic complications
Hansoo Kim +3 more
doaj +1 more source
Fenofibrate modified-release pellets with lag phase and high oral bioavailability
Fang Li,1,* Xin Zheng,2,* YongChu Bao,3 Ting Chen,3 Jia Zeng,1 XiaoLi Xu,4 Chao Yan,5 LingLin Feng1 1NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, and Shanghai Engineer and ...
Li F +7 more
doaj
Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression. [PDF]
O'Brien RC +9 more
europepmc +1 more source
Association of fenofibrate therapy with cardiovascular events and mortality in diabetes patients with early-diagnosed hyperlipidemia. [PDF]
Liu H +9 more
europepmc +1 more source
Fenofibrate suppresses Mycoplasma bovis infection via autophagy-mediated cholesterol regulation in bovine mammary epithelial cells and murine mammary tissue. [PDF]
Xu M +9 more
europepmc +1 more source
Fenofibrate attenuates the adverse effects of radiation on endothelial cells through modulation of ROS-NO signalling and inflammation. [PDF]
Elsaeed O +8 more
europepmc +1 more source
PPARa-FSP1 axis modulates lipid peroxidation-induced neuronal ferroptosis to promote functional recovery in mouse model of traumatic spinal cord injury. [PDF]
Song Y +8 more
europepmc +1 more source
Drug-induced renal function deterioration in a patient with polyarteritis nodosa. [PDF]
Iturgoyen-Fuentes DP.
europepmc +1 more source
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus. [PDF]
Lai ST +6 more
europepmc +1 more source
Hepatic-vascular crosstalk via GRK2: fenofibrate improves endothelial function by restoring lipid metabolism and NO signaling in obese mice. [PDF]
Taguchi K +4 more
europepmc +1 more source

